Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Sep;30(9):7615-7623.
doi: 10.1007/s00520-022-07194-0. Epub 2022 Jun 8.

Management of malignant cutaneous wounds in oncologic patients

Affiliations

Management of malignant cutaneous wounds in oncologic patients

Michela Starace et al. Support Care Cancer. 2022 Sep.

Abstract

Purpose: Neoplastic wounds may develop as a result of primary tumor growth in the skin, due to metastasis, or due to skin invasion by tumors emerging from deeper levels. Malignant wounds may present as a crater-like ulcer, or as raised nodules with a cauliflower-like appearance. They are associated with malodor, necrosis, pain, bleeding, and secondary infection. The aim of our study is to better characterize fungating wounds and their management.

Methods: We retrospectively reviewed the database of the Wound Care Unit of the University of Bologna in order to identify individuals affected by neoplastic wound, between January 2019 and February 2021.

Results: We identified 9 females and 2 males with a mean age of 63 years; all were referred by the Oncology Unit. Management differed depending on the characteristics of the patients and the ulcers. Complete healing of the wound, following the parallel complete remission of the lymphoproliferative neoplasia, was observed in one individual. Among the others, one died because of breast cancer, while cutaneous lesions in 2 individuals deteriorated after 1 year of follow-up. Remission/relapse of the ulcer following the treatment course administered for the lymphoma were observed in one patient.

Conclusions: Treatment of malignant fungating wounds is challenging. Considering the neoplastic nature of the wounds, complete healing or improvement cannot be expected with the application of classically prescribed dressing for wounds. A mostly palliative treatment, focusing on maintaining the patient's quality of life, is a reasonable choice.

Keywords: Breast cancer; Malignant wound; Management of wounds; Neoplastic wounds; Oncology.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
Clinical presentation of our case series: see Table 1 for patient’s characteristics (from “A” to “L”)
Fig. 2
Fig. 2
Patient “M.” A First clinical evaluation. B 6 months post treatment with hydrogel dressing

References

    1. Meaume S, Fromantin I, Teot L (2013) Neoplastic wounds and degenerescence. J Tissue Viability [Internet]. Elsevier Ltd; 22:122–30. Available from: 10.1016/j.jtv.2013.07.001 - PubMed
    1. Alexander S (2009) Malignant fungating wounds: epidemiology, aetiology, presentation and assessment. J Wound Care 18 - PubMed
    1. da Costa Santos CM, de Mattos Pimenta CA, Nobre MRC. A systematic review of topical treatments to control the odor of malignant fungating wounds. J Pain Symptom Manage. 2010;39:1065–1076. doi: 10.1016/j.jpainsymman.2009.11.319. - DOI - PubMed
    1. Seaman S. Management of malignant fungating wounds in advanced cancer. Semin Oncol Nurs. 2006;22:185–193. doi: 10.1016/j.soncn.2006.04.006. - DOI - PubMed
    1. Tsichlakidou A, Govina O, Vasilopoulos G, Kavga A, Vastardi M, Kalemikerakis I. Intervention for symptom management in patients with malignant fungating wounds - a systematic review. J BUON. 2019;24:1301–1308. - PubMed

LinkOut - more resources